Dr. Gerberding joined the FNIH as CEO on May 16, 2022. She served before that as President of Merck Vaccines and as Executive Vice President and Chief Patient Officer at Merck & Co., Inc. From 2003-2009, she directed the U.S. Centers for Disease Control and Prevention (CDC).

Dr. Gerberding is a member of the National Academy of Medicine and the adjunct faculties of the University of California, San Francisco, and Case Western Reserve University. Her current board service includes Mayo Clinic, Case Western Reserve University, Research!America, National Health Council, HilleVax, and Artidis. She also co-chairs the CSIS Bipartisan Alliance for Global Health Security.

Dr. Gerberding received her undergraduate and M.D. degrees from Case Western Reserve University and a Master of Public Health at the University of California, Berkeley. She completed her internship and residency in Internal Medicine and fellowship in Clinical Pharmacology and Infectious Diseases at the University of California, San Francisco, where she is currently an Adjunct Associate Professor of Medicine.